Metabolomics in Cancer: Turning Biological Insight into Clinical Impact

Metabolomics is transforming how we understand cancer. Unlike genomics or transcriptomics, metabolomics captures real-time biochemical activity, making it a powerful approach to understand tumor behavior, reveal functional biology, uncover clinically relevant biomarkers, and enable new approaches to early detection and patient stratification.

In this webinar, we will explore how metabolomics provides a powerful lens into tumor biology and how these insights can be translated into real-world clinical applications. Through a series of case studies, we will highlight how metabolic profiling can reveal key disease mechanisms, distinguish tumor subtypes, and identify biomarkers in accessible samples such as blood and urine.

Attendees will gain a clear view of how metabolomics is bridging the gap between basic biological discovery and real-world clinical applications to support advances in precision oncology, minimally invasive diagnostics, and risk prediction.

What you will learn:

• Why metabolomics is a game-changer in oncology research
  • Move beyond genomics to capture real-time, functional biology
  • Understand how metabolism reflects tumor state and disease progression
• Translation of tumor tissue insights into non-invasive biomarkers
  • Learn how tumor-derived metabolic signals can be detected in blood and urine
  • See how metabolomics enables patient stratification without invasive procedures
• How metabolomics supports earlier detection and risk assessment
  • Discover emerging approaches for identifying cancer before clinical symptoms
  • Understand how metabolic changes can signal disease risk years in advance
• Real-world applications across oncology
  • From breast to liver to brain cancers
  • Examples spanning preclinical models, clinical cohorts, and population studies